Lokman Hekim Engurusag (LKMNH) Fundamental Analysis
This page summarises the financial statements and the KapAI scorecard of Lokman Hekim Engurusag (LKMNH) in the İlaç ve Sağlık sector for the 2026/6 period. Figures are compiled from the company’s reported balance sheet and income statement, in millions of Turkish lira.
Company Information
- Company: Lokman Hekim Engurusag
- Ticker: LKMNH
- Sector: İlaç ve Sağlık
- Latest reporting period: 2026/6
KapAI Scorecard
Overall score: 1.8 / 5
- Profitability: 3.3 / 5
- Liquidity: 1.5 / 5
- Leverage: 1.3 / 5
- Efficiency: 1.0 / 5
Summary Income Statement (TRY million)
Period: 2026/6 · Compared with: 2025/6
| Item | 2026/6 | 2025/6 | Change |
|---|---|---|---|
| Revenue | 2,650 | 2,377 | +11.5% |
| Gross Profit | 484 | 385 | +25.5% |
| Operating Profit | 460 | 221 | +108.0% |
| EBITDA | 0 | 0 | — |
| Net Monetary Position Gains | 183 | 133 | +38.1% |
| Net Profit for the Period | 75 | 90 | -16.9% |
Summary Balance Sheet (TRY million)
Period: 2026/6 · Compared with: 2025/6
| Item | 2026/6 | 2025/6 | Change |
|---|---|---|---|
| Current Assets | 2,671 | 1,299 | +105.7% |
| Non-Current Assets | 4,502 | 3,121 | +44.2% |
| Total Assets | 7,173 | 4,419 | +62.3% |
| Current Liabilities | 3,292 | 1,605 | +105.2% |
| Non-Current Liabilities | 859 | 414 | +107.6% |
| Total Liabilities | 4,151 | 2,018 | +105.7% |